Skip to content

Study examines role of AZT and d4T in metabolic changes

Some groups get more benefit from anti-HIV drugs than others

Poor immmunologic response to HAART should be cause for concern in viral load responders

Selective taking of anti-HIV drugs associated with higher rate of AIDS and death

New tablet formulation of Kaletra approved in US

Severe muscle damage seen in patient treated with abacavir and lipid-lowering fibrate

High incidence of TB after ART started, MSF reports

Second company halts CCR5 inhibitor study in another blow to new drug class

Unusual side-effects or drug interactions? UK's safety regulator wants to hear from you